Below 30 Hp Centrifugal Water Pump Market Development Status, Competition Analysis, Type and Application.

Future Market Insights (FMI) delivers key insights on the Egypt below 30Hp centrifugal water pump market in its upcoming market forecast and outlook titled, “Below 30 Hp Centrifugal Water Pump Market: Egypt Industry Analysis and Opportunity Assessment 2015 – 2020”. The Egypt below 30 Hp centrifugal water pump market is projected to register a steady CAGR of 5.1% in terms of revenue during the forecast period due to various factors, regarding which FMI offers vital insights in detail.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-eg-704

FMI analyses the Egypt below 30Hp centrifugal water pump market in terms of market value (US$ Mn) and volume (units), by applications, pump type and pump capacity, and provides insightful information regarding market dynamics, value chain, competitive landscape, current trends, market estimations and forecast until 2020.

Below 30Hp centrifugal water pumps are the most used types of pumps in the world due to robust and effective nature. Below 30 Hp centrifugal water pumps find application in various large and small scale industries such as chemicals, construction, waste water treatment and agriculture. On the basis of application type, the market has been segmented into industrial, agriculture and domestic use. The domestic application segment accounted for around 40% revenue share of the overall Egypt below 30Hp centrifugal water pump market in 2014, and is expected to register a CAGR of 4.8% over the forecast period. Agriculture application is estimated to grow at the fastest CAGR during the forecast period. Every application segment is further sub-segmented into monobloc, mini pump and submersible pump. Submersible pumps are widely preferred for all the above mentioned applications; however, monobloc pumps is expected to register a high CAGR over the forecast period. Submersible centrifugal water pumps are widely preferred in Egypt, and account for over 50% share of the Egypt below 30Hp centrifugal water pumps market.

This report covers trends driving growth of each segment and respective sub-segments and offers pricing analysis and insights for each pump type and their respective capacities. From the capacity perspective, segmentation is done on the basis of horsepower for all three types of pumps. A detailed pricing analysis is done for the same. The 25 to 30 Hp pump in the monobloc and submersible pump category are more preferred, while the 1 to 2 Hp capacity pumps account for over 50% share in the mini centrifugal water pump category.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-eg-704

Increasing investment in housing construction, infrastructure development, expansion of water supply network and increase in agriculture initiatives are some of the macro-economic drivers for the Egypt below 30Hp centrifugal water pump market. Political instability and price volatility are some of the factors restricting growth of the Egypt below 30Hp centrifugal water pump market. Prices of China-made centrifugal water pumps are relatively lower and this is one of the major concerns for global and regional players operating in this market. Adoption of photovoltaic powered centrifugal water pumps and solar powered centrifugal water pumps is trending in the Egypt below 30Hp centrifugal water pumps market.

Key players in the Egypt below 30Hp centrifugal water pump market include Grundfos, KSB Pumps, Xylem Inc., Wilo, Flowserve Corporation, Calpeda and Omega Engineering Egypt. Egypt centrifugal water pump market is largely dominated by regional and local players, and these collectively account for around 70% share of the total centrifugal water pump market. Grundfos accounts for largest share among all others, followed by KSB Egypt and Wilo.

Key Segments Covered

  • Industrial
    • Mini Pumps  (0.5-30 HP)
    • Monobloc Pumps (0.5-30 HP)
    • Submersible Pumps (0.5-30 HP)
  • Agriculture
    • Mini Pumps (0.5-30 HP)
    • Monobloc Pumps (0.5-30 HP)
    • Submersible Pumps (0.5-30 HP)
  • Domestic
    • Mini Pumps (0.5-30 HP)
    • Monobloc Pumps (0.5-30 HP)
    • Submersible Pumps (0.5-30 HP)

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/704

Contact Us:                                                            

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

U.S.Plastic-to-fuel Market Competitive Growth Strategies Based on Type, Applications, End User.

The U.S. Plastic-to-fuel market is driven by number of factors such as increasing use of plastic, leading to easy availability of feedstock. As estimated by the U.S. Environmental Protection Agency (EPA), plastics accounted for approximately 12.7% of the total Municipal Solid Waste (MSW) generation in the U.S. in 2012.

Future Market Insights (FMI) announces the release of its latest report titled, “Plastic-to-fuel Market : U.S. Industry Analysis and Opportunity Assessment 2015 – 2020”. As per FMI’s projection, the U.S. Plastic-to-fuel market is estimated to generate US$ 42.78 million in revenues in 2015, which is likely to reach US$ 98.26 million in 2020 representing a CAGR of 6.79% through the forecast period of 2016 to 2020.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-us-448

Strong need for an alternative fuel due to depleting natural hydrocarbon resources across the globe is also a strong driver for growth of the U.S. plastic-to-fuel market. Furthermore, increasing tipping cost of landfills, coupled with a need for solid plastic waste recycling technology is amongst key factors leading to growth in the market.

However, high initial setup cost of waste processing facilities, in addition to technological complexities occurring due to delicate relationship between type of waste plastic processed, technology, and the output can pose key challenges for growth.

Revenue Generated through Sale of Processor: Key Segment in the U.S. Plastic-to-Fuel Market

The U.S. plastic-to-fuel market is segmented on the basis of revenue generation models followed by key market players. Revenue generation models include revenue earned through sale of processors, revenue earned by sale of fuel produced using conversion technology, and revenues grossed through royalties.

Amongst other segments, revenue generated through sale of processor is estimated to account for approximately 70% of the total plastic-to-fuel market in the U.S. However, revenues earned through royalties is anticipated to witness a CAGR of 7.81% during the forecast period, despite expected to account for a negligible share in revenue in 2020.

Revenue generated through sale of fuels is estimated to account for less than 40% of the total market in 2020. This model is likely to exhibit a lower CAGR as compared to other segments, which can be attributed to a number of technical difficulties faced during the plastic-to-fuel conversion process.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-us-448

Competitive Landscape

Key players in plastic-to-fuel business in the U.S. are Plastic2Oil, Vadaxx Energy, Agilyx Corporation and RES Polyflow. The companies active in the market are undergoing expansion plans within and outside the countries. However, one of the key players in the market recently announced closure of one of the plastic-to-oil production facility.

Key market players target landfills, municipalities and major industrial plastic waste generators to ensure constant feedstock availability. Companies are raising capital through equity investors to implement these conversion technologies.

U.S. Plastic-to-fuel Market Segmentation by Revenue Generating ModelThe U.S. plastic-to-fuel market has been segmented in to three revenue generating models, wherein the market revenues can be generated through sale of processors, sale of fuels and royalties earned by companies with proprietary technologies. The revenue generated through sale of processors accounted for the leading share in 2020.

U.S. Plastic-to-fuel Market: Government GrantsAs far as the government grants for recycling technologies is concerned, Pyrolysis, which is widely used to convert waste plastic into fuel is not eligible for recycling grants offered by state governments.

This is due to the fact that the technology is not categorized under recycling technology and is called conversion technology. However, it can still fetch government grants for green job creation and credits incentives for starting a unit in rural area.

Key Segments CoveredThe report analyses U.S. Plastic-to-fuel market on the basis of following segments:

  • Revenue generation model
    • Fuel
    • Processors
    • Royalties
  • End Products
    • Crude Oil
    • Diesel

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/448

Contact Us:                                                                            

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Produced Water Treatment Systems Market 2022 | Scope of Current and Future Industry 2029

FMI has segmented the produced water treatment systems market on the basis of technology into primary, secondary, and tertiary. Future Market Insights (FMI) offers an overview of the key technologies used in produced water treatment systems in its research report. The report titled, “Produced Water Treatment Systems Market: Global Industry Analysis and Opportunity Assessment 2022-2029, forecasts the market to amplify at a compound annual growth rate (CAGR) of over 5.8% during the forecast period.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb–86

Primary treatment technologies employ basic, such as settling, media filtration, floatation, and biological aerated filtering to separate solids from water. According to FMI’s research, Alderley plc is one of the dominant players in the primary treatment technologies.

produced water treatment systems market

Secondary treatment technologies involve the use of induced gas floatation, degasser, and membrane separation. Twin Filter BV is a dominant company providing secondary treatment technology in the market.

Tertiary treatment technologies involve the use of absorption and polishing to separate oil content in produced water. These technologies use a combination of technologies to treat produced water. According to FMI, ProSep, Inc. is the dominant player in tertiary treatment technology.

FMI has analysed the produced water treatment systems market in North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

North America is the most lucrative region in the global produced water treatment systems market, accounting for nearly one-third of the global market revenue. In terms of CAGR, the North America produced water treatment systems market is expected to expand at over 8% during the forecast period 2014-2020.

In terms of market share, North America is expected to gain 590 BPS during the forecast period. FMI’s analysis revealed that although all three technologies are widely used in North America, tertiary technology was the largest in terms of market revenue, accounting for US$ 574 Mn in 2014. FMI expects the tertiary technology segment to expand at a double-digit CAGR during the forecast period.

Tertiary technology is more effective than both primary and secondary technology, owing to which it is being widely adopted by end-use industries. The tertiary technology segment of North America is expected to gain a whopping 1310 BPS during the forecast period.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb–86

Onshore crude oil industry in North America represented 49.14 Bn barrels or nearly 80% of produced water in 2012. FMI expects this to reach 116.29 Bn barrels by the end of 2020.

Asia Pacific is the second largest market for produced water treatment systems after North America. The Asia Pacific produced water treatment systems market was worth US$ 960 Mn in 2014; FMI expects it to expand at a CAGR of over 2.8% during the forecast period 2014-2021.

FMI has segmented the competitive landscape of global produced water treatment systems market into treatment systems, mobile systems and rental service, and commissioning and consulting services.

Competitive Landscape

The produced water treatment systems market is highly competitive in nature. Leading market players are upgrading their product portfolio. Besides this, they have adopted various organic and inorganic strategies such as partnerships, advanced product launches, collaborations and acquisitions to dominate the market. For instance,

  • In March 2021, Heartland Technology partnered with Power-On-Demand, the oil and gas cogeneration solution provider, to deliver innovative, combined power-water solutions to the energy industry that generate cleaner on-site power with reduced greenhouse-gas (GHG) emissions, while providing cost-effective, reliable solutions for produced water disposal and reuse.
  • In May 2016, GE launched a new water treatment technology called ZeeWeed 700B for the offshore oil and gas industry.
  • In November 2021, Ovivo Inc., a global provider of water and wastewater treatment equipment, technology and systems, invested over 25 million US dollars for the construction of a state-of-the-art facility that will produce Cembrane’s unique patented Silicon Carbide flat sheet membranes in the United States.
In July 2020, Veolia Water Technologies launched TERION, a standard single-skid unit which combines single pass reverse osmosis and continuous electrodeionization to produce high-grade deionized water for laboratory, power, and general industry.

Key Questions Answered in the Report

  • What is the current produced water treatment systems market valuation?

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/86

Contact Us:                                                            

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Lead Acid Battery Market 2022 Outlook, Current and Future Industry Landscape Analysis 2031

The global sales of lead acid battery are set to be valued at over US$ 54.3 Bn in 2021, with a stable long-term projection, according to latest insights by Future Market Insights (FMI). The report has forecast the market to expand at over 5.2% CAGR between 2021 and 2031.

According to the market analysis by Future Market Insights, expansion of automotive production facilities to cover rural and other remote areas has led to the increasing demand for lead acid battery. Rapid technological advancements in production technologies are also projected to complement market growth over the coming years.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-54

Demand for lead acid battery is increasing with the rise in the volume of vehicle fleet in recent years. This can be attributed to an increase in aftermarket sales in regular interims for battery replacement.

The growing requirement has led to mass production and has increased importance of process automation in the lead acid battery market. The market is shifting towards industry 4.0 s, leading to the universal adoption of new production technologies.

There also is an increasing demand from other industries for deployment of lead acid battery. Increasing number of players focusing on research and development related to lead acid battery is anticipated to have a significant contribution towards market growth in the years to come.

Key Takeaways from Lead Acid Battery Market Study

  • Flooded battery is projected to hold over 49% of the global market share in 2021 in terms of product type, supported by superior configurations.
  • Transportation is projected to hold over 56% of the overall market share as leading segment in terms of application by 2031-end, supported by increasing investments in electric vehicles production.
  • China will remain a chief market, backed by rising demand from the automotive industry. It is expected to account for over 57.3% of demand registered in East Asia in 2021.
  • The markets India is set to surge at around 6% CAGR over the next ten years.
  • Germany is emerging as a key market in Europe, accounting for over US$ 2,509.4 Mn in 2021, driven by expansion of the automotive industry.

“The lead acid battery market is growing at a strong pace, driven largely by increasing demand for energy efficient solutions across automotive sector. The increasing demand for electric vehicles will create extensive opportunities for manufacturers. Key industry participants have been focusing product diversification to offer energy efficient solutions and gain a competitive advantage,” says a Future Market Insights analyst

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-54

Competitive Landscape

The lead acid battery market is highly competitive at regional as well as global levels, and highly consolidated in nature. These players are likely to invest in new technology developments and expansion of their networks in order to maintain their market shares.

Some of the key players in this industry include but are not limited to Furukawa Electric Co., Ltd., Narada Power Source Co. Ltd., Clarios, Leoch International Technology Ltd., Enersys, Exide Industries Ltd., GS Yuasa Corporation, East Penn Manufacturing Co., Chaowei Power Holdings Limited., and others.

Find More Valuable Insights

The research report analyzes demand for Lead Acid Battery. The global Lead Acid Battery market has been analyzed with the COVID-19 impact, various macroeconomic factors, market trends and market background. As per Future Market Insights, the market has been analyzed on the basis of product type, power source, and region. The report provides qualitative and quantitative information on various players in this market. This report also tracks the market by both, supply side and demand factors.

Key Questions Answered in the Report

  • What is the current valuation of lead acid battery market?
  • At what rate will the Japan lead acid battery market grow?

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/54

Contact Us:                                                            

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Whole Genome Amplification Market 2021 Outlook, Current and Future Industry Landscape Analysis 2031

The global whole genome amplification market is estimated at around US$ 5.08 Bn by the end of 2031, as indicated by a recent report released by Future Market Insights. The global market for whole genome amplification will possibly expand at a CAGR of 7.9% during the forecast period, 2021-2031

A US-based team of researchers has recently developed a microfluidic device for isolating a genomic DNA, which is to be purified later. This DNA is sourced from individual cells and the device physically catches single cells using a micropillar array.

It also captures chromosomal DNA of these single cells post-extraction, which is later immobilized in the micropillar array so as to enable the process of isothermal amplification. The entire methodology is referred to as ‘on-chip cell capture and DNA extraction’.

As conventional single cell WGA is often prone to amplification biases, which may hold a significant influence on the accuracy of the data of single cell sequencing.

This drawback is foreseen to be overcome with the introduction of single cell on-chip WGA, resulting in reduced biases regarding amplification, offering an improved coverage of the genome. The team has used individual cancer cell genomes (human), sourced from the HeLa Cell Line.

WGA has been a crucial procedure that helps in DNA analysis from limited quantities of genomic DNA. The ease provided by various WGA kits available for the entire process has been driving the market over the years.

Increasing research activities will remain the key factor pushing the growth of whole genome amplification market over the next decade. Adoption of this process is expected to witness robust growth, predominantly among research institutes, hospitals, diagnostic centers, and forensic labs, as it offers an improved and advanced means of genome amplification and sequencing.

To increase the revenue share, molecular testing companies are focusing more on the development of advanced devices and kits such as WGA kits and complete WGA kits with advanced capabilities.

The global whole genome amplification market is estimated at around US$ 5.08 Bn by the end of 2031, as indicated by a recent report released by Future Market Insights. The global market for whole genome amplification will possibly expand at a CAGR of 7.9% during the forecast period, 2021-2031.

Single Cell WGA Continues to Bring in New ApplicationsIntroduction of massively parallel single-cell genome sequencing is anticipated to offer a new dimension to the understanding of genetic diversities in complex biological systems.

Single cell WGA is a method used to examine the sequence information with the optimized next generation sequencing technologies, only from a single cell. This method is considered to be a powerful tool that helps to understand the ins and outs of genetics by bringing the entire genome structure to a cellular level.

Since this method offers a high-resolution view of the genomic sample, its adoption will continue to be on the rise in diverse biological fields such as microbiology, immunology, neurobiology, cancer research, and tissue mosaicism.

Single cell WGA also plays a crucial role in conveying new applications to the market, eventually pushing the market growth further through 2031.

Request Complete TOC Of this Report @ https://www.futuremarketinsights.com/toc/rep-gb-1873

New Technology Assessment in Branded WGA ProductsAs a move towards better results and implementation of advanced technology, novel techniques are being introduced in the new WGA products.

The TruePrime Single Cell WGA Kit (Expedeon Ltd.), utilizes a unique and reliable method to achieve accurate genome amplification from single cells. TruePrime technology uses a revolutionary novel multiple displacement amplification (MDA) method based on the combination of the recently discovered DNA primase “TthPrimPol” and the extremely processive and high-fidelity Phi29 DNA polymerase to amplify uniformly total genomic DNA either a single or a few cells.

Similarly MALBAC Multiple annealing and Looping Based Amplification Cycles) technology and PicoPLEX® WGA kit (Rubicon Genomics), with patented technology are the other options that have been unveiled as the latest and advanced technologies which are more efficient and optimized in the results and analysis outcomes.

Companies Focusing on Better Product Quality through Life Science ResearchIncreasing prevalence of infectious diseases and oncology disorders has increased the demand for WGA devices and kits, fueling the growth of companies dealing in WGA kits.

Despite the market having several large players as well as multiple smaller companies, there are limited companies that have a complete focus on being a provider of life science products and reagents.

Vendors have different specializations and product offerings, with most of the large companies combining research products and reagents with equipment, in-vitro diagnostics tools etc.

However, the companies that have a sole focus on this market can have better growth prospects in the coming future.

They can ensure better quality of products, customer loyalty and an established distribution network that can cater to product availability around the globe.

The key players of the market, including GE Healthcare, Sygnis AG, Illumina, Inc., Merck KGaA, Thermo Fisher Scientific Inc., and Active Motif are inclined more towards strategic acquisitions and mergers.

They are also looking for distribution and collaboration agreements to help improve their product reach. It will also help them serve end users better, with diagnostic consulting and good laboratory practices. High price point may remain a major challenge for companies.

Orthokeratology Market 2022 Outlook, Current and Future Industry Landscape Analysis 2028

Orthokeratology has been considered to facilitate the elimination of contact lens related vision problems, providing patients with the freedom to experience an active lifestyle.

While this factor will continue to play a pivotal role in growing adoption of Ortho-K lenses, Future Market Insights has discovered a few other factors that are likely to impact the growth of orthokeratology market in near future. In a recently released report, titled “Orthokeratology Market: Global Industry Analysis 2013-2021 and Opportunity Assessment, 2022–2028,” the performance of global market for orthokeratology is assessed for a 10-year period 2022-2028.

Increasing online efforts in patient education and awareness about Ortho-K, coupled with an intensifying rate of success of orthokeratology lenses in recent years, is expected to strengthen the prospects for global orthokeratology market, over the next decade. The market is likely to witness a promising CAGR of 7.4%; whereas, the global revenue is anticipated to reach beyond US$ 88 million by the end of 2028.

While increasing prevalence of myopia stands as a key factor impacting the market growth, several advantages of Ortho-K lenses over the conventional contact lenses have been recognized to be pushing adoption of orthokeratology among sports persons. A few restrictions arising in case of LASIK surgery will also be reportedly responsible for growing inclination for Ortho-K. On the flipside, the adoption of orthokeratology lenses among the myopic patient is less than 0.5%, which is a major factor deterring the growth of the market. In few under developing economies, patient are not able afford the high cost of ortho-k lenses and also the high fees of ophthalmologists and optometrists which will also deter the growth of market to some extent.

Orthokeratology Market Historical Analysis (2013-2021) Vs. Market Outlook (2022-2028)The global orthokeratology market value increased at around 6.9% CAGR from 2013 to 2021.

Orthokeratology (Ortho-K), an emerging treatment option for myopia, presbyopia, hyperopia, and astigmatism, is a non-invasive process and works on the principle of corneal replacement. At present, there are two FDA approved Ortho-K therapies: Corneal Refractive Therapy (CRT) and Vision Shaping Treatment (VST).

Patients availing these treatments need to wear the Ortho-K lenses for 6 to 8 hours at night during their sleep, and this reshapes their cornea to facilitate clear vision during the daytime.

Orthokeratology has been considered to facilitate the elimination of contact lens-related vision problems, providing patients with the freedom to experience an active lifestyle. While this factor will continue to play a pivotal role in the growing adoption of Ortho-K lenses.

Increasing online efforts in patient education and awareness about Ortho-K, coupled with an intensifying rate of success of orthokeratology lenses in recent years, is expected to strengthen the prospects for the global orthokeratology market, over the coming years.

While increasing prevalence of myopia stands as a key factor impacting market growth, several advantages of orthokeratology lenses over conventional contact lenses have been recognized to be pushing the adoption of orthokeratology devices among sportspersons.

The orthokeratology market is projected to expand at a CAGR of around 7.3% from 2022 to 2028.

Orthokeratology market

Request Complete TOC Of this Report @ https://www.futuremarketinsights.com/toc/rep-gb-3142

Myopia Continues to Remain the Most Influencing Indication, Accounting for a Major Revenue ShareMyopia is expected to remain a key indication driving the demand for orthokeratology, worldwide. With over 70% share of the total market value estimated for 2028, myopia will also provide an extensive scope for innovation opportunities. Hyperopia, followed by astigmatism, will represent the next key indicative factor, which is anticipated to drive market growth over the forecast period.

Demand from Optometry Clinics Accounts for a Share that Equates More than Half of the Market ValueAmong all distribution channels, optometry clinics will reportedly continue to generate the maximum demand for Ortho-K, accounting for a share of more than 50% to the total market value through 2028. Ophthalmic clinics are expected to hold a decent revenue share throughout the assessment period, whereas hospitals are likely to emerge as the most opportunistic distribution channel.

MEA Still Struggles through Low Awareness LevelNorth America and Europe, which represent the key regional markets, will reportedly account for a collective value share of around 60% through 2028. Asia Pacific excluding China and Japan is slated for modest growth, whereas MEA will continue to witness sluggish growth rate owing to relatively lower consumer awareness about availability and use of Ortho-K lenses.

Key Segments Covered in Orthokeratology Industry SurveyOrthokeratology Market by Indication

  • Myopia
  • Presbyopia
  • Hyperopia
  • Astigmatism

Orthokeratology Market by Distribution Channel

  • Hospitals
  • Optometry Clinics
  • Ophthalmology Clinics

Orthokeratology Market by Region

  • North America Orthokeratology Market
  • Latin America Orthokeratology Market
  • Europe Orthokeratology Market
  • East Asia Orthokeratology Market
  • South Asia & Pacific Orthokeratology Market
  • Middle East & Africa (MEA) Orthokeratology Market\

Arthroscopy Procedure and Products Market 2021 Outlook, Current and Future Industry Landscape Analysis 2031

ESOMAR-certified consulting firm Future Market Insights, in its updated report, projects a steady growth of the arthroscopy procedures and products market between 2021 and 2031. The market is expected to reach a valuation of approx. US$ 6488.4 Mn in 2021.

Rising prevalence of knee osteoarthritis among geriatric population and increasing number of knee arthroscopy conducted worldwide have augmented the market growth. Increasing application in sports medicine, and ease in regulatory approval such as the U.S. Food & Drug Administration are the factors driving growth.

Due to the non-invasive nature and benefits of arthroscopy, patients suffering from severe osteoarthritis are preferring knee arthroscopy, which is accelerating the market growth.

Growing incidence of osteoarthritis across the U.S., Germany, the UK, and China have propelled the adoption of knee arthroscopy surgeries in those regions.

With such rising statistics, healthcare professionals and government are increasing the initiatives to provide rehabilitation and facilities to curb the additional cost. Based on such factors, the market is anticipated to witness healthy growth at over 7.7% CAGR during 2021 and 2031.

However, increasing risk of edema and other infections such as blood clots in the joints might restrict the market growth. Also, high cost of surgery and procedures across low economies such as Brazil, India and other countries in Latin America will hamper the market growth.

Key Takeaways from FMI’s Arthroscopy Procedures and Products Market Study

  • In terms of procedure type, knee arthroscopy will account for over 50% of the global market share
  • Arthroscopic implants segment will account for highest share of the arthroscopy procedures & products market during the forecast period
  • The U.S. will emerge as the most lucrative market backed by the rising prevalence of degenerative disease among geriatric population
  • Germany and the U.K., collectively, will emerge as the most lucrative market across Europe in the upcoming decade
  • Japan is anticipated to emerge as a lucrative market backed by the high prevalence of rheumatoid arthritis and osteoarthritis among elderly

 “Increasing prevalence of osteoarthritis and growing degenerative disease among elderly population have encouraged the leading players to engage in research & development activities to develop advanced procedure & instrument for non-invasive surgeries,” says the FMI analyst. 

Request Complete TOC Of this Report @ https://www.futuremarketinsights.com/toc/rep-gb-1386

Competitive LandscapeProminent players in the market are focusing on strategic mergers and collaboration to expand their global footprint in the market.

New product launches coupled with increasing research & development activities for the development of advanced arthroscopy instruments & devices will also be one of the key strategy to enhance their customer base for market players.

For instance, couple of years back, leading player, Smith & Nephew entered into a distribution agreement with OrthAlign, a U.S. based private company to develop medical devices and distribute their Total-Knee Arthroplasty (TKA) technology across several countries in Africa and Middle East.

Also, in 2018, Ceterix® Orthopedics, Inc., a leader in the development of cutting-edge surgical tools for orthopedic surgeons announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of NovoStitch® Pro Meniscal Repair System – a size 0 suture cartridge – offering surgeons more options to repair meniscal tears for arthroscopic surgeries.

Arthroscopy Procedure and Product Market by CategoryBy Product Type:

  • Arthroscopes and Visualization Systems
  • Arthroscopic Resection Systems
  • Arthroscopic Fluid Management Systems
  • Arthroscopic Implants
    • Knee Implants
    • Shoulder Implants
    • Hip Implants
    • Other Implants
  • Arthroscopy Radiofrequency (RF) Systems
  • Arthroscopic Drills and Fixation Systems
  • Other Arthroscopy Instruments and Accessories

By Procedure Type:

  • Shoulder Arthroscopy
  • Hip Arthroscopy
  • Knee Arthroscopy
  • Elbow Arthroscopy
  • Small Joints Arthroscopy
  • Others

By Region:

  • North America
  • Latin America
  • Eastern Europe
  • Western Europe
  • Asia Pacific excluding Japan
  • Japan
  • Middle East and Africa (MEA)

Europe Viscosupplementation Market 2016 Outlook, Current and Future Industry Landscape Analysis 2026

Future Market Insights (FMI) delivers key insights on the Europe viscosupplementation market in its upcoming report titled, “Viscosupplementation Market: Europe Industry Analysis and Opportunity Assessment, 2016-2026”. In terms of revenue, the Europe viscosupplementation market is projected to register a healthy CAGR of 5.1% during 2016-2026.

FMI’s report has segmented the market on the basis of product type, end user and region.

Based on product type, the market has been segmented into one injection viscosupplementation, three injection viscosupplementation and five injection viscosupplementation.

Single injection viscosupplementation product type segment is expected to emerge as the most popular segment over the forecast period, driven by better patient compliance as the treatment reduces the need for multiple hospital visits. The segment is expected to register the highest CAGR of 6.7% during the forecast period.

Five injection viscosupplementation product type segment is expected to witness a decline in market share in terms of revenue from 29.0% in 2015 to 23.3% in 2026. This decline is attributed to more incidence of side effects and repeated patient visit requirements associated with five injection viscosupplementation. Reimbursement cutbacks and high injection costs are other factors that can curtail demand for five injection viscosupplementation.

By end-users, the market is segmented into hospitals, ambulatory surgical centres and orthopaedic clinics. Hospitals end-use segment is expected to witness significant demand for viscosupplementation, registering a CAGR of 4.3% over the forecast period. Better reimbursement options and increasing patient preference for single injection cycle for osteoarthritis treatment is expected to drive demand for one injection viscosupplementation in the orthopaedic clinics segment over the forecast period.

Browse the full “Viscosupplementation Market: Europe Industry Analysis and Opportunity Assessment, 2016 – 2026” market research report at https://www.futuremarketinsights.com/reports/europe-viscosupplementation-market

Europe Viscosupplementation Market Trends

Key trends in the viscosupplementation market are the use of single injection cycle for osteoarthritis treatment and introduction of new combination products in the market. For example, the product pipeline of major players in the viscosupplementation market involves combining corticosteroid injections, which help in relieving pain associated with osteoarthritis, with long-lasting effects of hyaluronic acid, which lasts for nearly six months. Further, regional competition within EU countries, especially in five injection cycle, is leading to entry of new market players. Europe is a mature market in terms of generic products and it is therefore relatively easier to obtain CE mark in Europe than it is to obtain the U.S. FDA approval.

Western Europe has been estimated to dominate the Europe viscosupplementation market in 2015, attributed to factors such as the presence of key regional players, strong distribution network and better healthcare infrastructure in the region.

Request Complete TOC Of this Report @ https://www.futuremarketinsights.com/toc/rep-eu-1383

Key Players in Europe Viscosupplementation Market

Some key players in the Europe viscosupplementation market are Anika Therapeutics Inc., Sanofi S.A., Zimmer Biomet Holdings, Meda AB, Ferring B.V, Fidia Pharmaceutici S.p.A,   and Bioventus LLC. We have discussed individual strategies followed by these companies in terms of enhancing product designs, creating new manufacturing facilities, market consolidation and advanced R&D initiatives. The report concludes with key takeaways that could help players already present in the market and new players planning to enter the market in the long run.

Key Segments

  • Product Type
    • Single Injection Viscosupplementation
    • Three Injection Viscosupplementation
    • Five Injection Viscosupplementation
  • End User
    • Hospitals
    • Ambulatory Surgical Centres
    • Orthopaedic Clinics

 Key Regions/Countries

  • Western Europe
    • U.K.
    • France
    • Germany
    • Spain
    • Italy
    • Nordics
    • Rest of Western Europe
  • Eastern Europe
    • Russia
    • Rest of Eastern Europe

Companion Animal Specialty Drugs Market 2021 Outlook, Current and Future Industry Landscape Analysis 2031

Future Market Insights, Dubai: As per ESOMAR-certified consulting firm Future Market Insights (FMI), the global companion animal specialty drugs market registered steady year-on-year (YoY) growth at 5.42% CAGR in 2021.

Increasing pet adoption is a major factor, fuelling the demand for animal nutrition and behavioral products, thereby accelerating sales. With increasing rate of obesity among the pet, demand for anti-obesity drugs have burgeoned over the past few years.

Adoption of canine and feline pets increased during the FQ-20, due to the outbreak of COVID-19 and consequent global shutdown. Adoption of dogs is quite high, especially among the geriatric population. This is expected to drive the demand for antibiotics, skin-care, and nutritional products for pets.

As per FMI, the market is expected to reach a valuation of US$ 36,104.66 Mn in 2021 owing to the increasing demand for anti-obesity drugs across veterinary clinics. Alongside this, prevalence of canine vector-borne diseases due to bacteria and protozoa infection will fuel the demand for parasiticides in the next decade.

Key Takeaways from FMI’s Companion Animal Specialty Drugs Market Study

  • By product type, parasiticides will dominate the market, accounting for over 32% of global market share.
  • In terms of distribution channel, veterinary clinics are expected to lead the segment contributing over 52% of value share by 2031
  • In terms of technology type, drying technology is predicted to exceed US$ 89 Bn by end 2031
  • The U.S. will emerge as the leading market across North America backed by the high adoption of pet dogs
  • Germany and the U.K. are anticipated to lead the Europe’s Companion animal specialty drugs market, owing to the growing obesity rate in dogs
  • Increasing cases of neglect and animal cruelty in India will bolster the demand for companion animal specialty drugs through 2021

“The demand for compounded medications and anti-obesity drugs for animals will continue increasing in the coming years. This has encouraged some of the leading companies to focus on research initiatives to launch novel drugs to facilitate improved care for companion animals. This will create impressive growth opportunities in the coming years,” says the FMI analyst. 

Competitive LandscapeZoetis Inc., Merck and Co., Inc., Bayer AG, Eli Lily and Co. and Boehringer Ingelheim GmbH are the key players operating in the companion animal specialty drugs market. among others are some prominent players operating in the Companion animal specialty drugs market.

For instance, in July 2020, Boehringer Ingelheim announced the launch of two new products, NexGard and Broadline, to provide comprehensive parasite treatment for dogs and cats, to expand their product portfolio for the India market.

As per the report, key players are focusing on product introduction and launches to expand their product portfolios. Key player are also involved extensively in strategic acquisition activities which has led to severe competition among companion animal specialty drugs market players.

For example, on August 4,2021, Zoetis, the Parsippany-based animal health company announced the acquisition of a leading Australian-based Jurox’s veterinary medicines, maker of livestock and companion animal medicines.

Request Complete TOC Of this Report @ https://www.futuremarketinsights.com/toc/rep-gb-3984

What else is in the report?Future market insights offers a unique perspective and actionable insights on companion animal specialty drugs market in its latest study, presenting historical demand assessment from 2016 – 2020 and projections from 2021-2031 based on product type (antibiotics, anti-inflammatory drugs, parasiticides, heartworm, behavioral products, nutritional products, anti-obesity drugs, skin care products and vaccines), distribution channel (veterinary hospitals, veterinary clinics and pharmacies and drug stores) in seven key regions (North America, Latin America, Eastern Europe, Asia Pacific excluding Japan, Western Europe, Japan and Middle East & Africa)

Companion Animal Specialty Drugs Market by CategoryBy Product:

  • Antibiotics
  • Anti-Inflammatory Drugs
  • Parasiticides
  • Heartworm
  • Behavioral Products
  • Nutritional Products
  • Anti-Obesity Drugs
  • Skin Care Products
  • Vaccines

By Distribution Channel:

  • Modern Trade
  • Online Distribution
  • Neighborhood Stores
  • Other Retail Format

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa (MEA)

Cell Line Development Market 2022 Outlook, Current and Future Industry Landscape Analysis 2028

According to International Agency for Research on Cancer, the number of new cancer cases per year is expected to rise to 23.6 million by 2030 globally. In recent times, cell line development and its applications are considered as potential tools in oncology research. Cell lines are projected to be used for development of new treatment pathway for various disease including cancer and neurological diseases.

Sales Analysis of Cell line Development from 2013 to 2021 Vs Market Outlook for 2022 to 2028

The market value for cell line development holds nearly 11.7% of the overall US$ 37.3 Mn drug discovery market in 2021.

Compared to the existing mammalian expression systems, the human cell lines possess the ability to produce proteins analogous to naturally synthesized proteins in the human body. This property is advantageous for the advancement in protein therapeutics, and acts as a heavy driver towards the growth of the biopharmaceutical industry. The growth of these industries pulls up the demand of cell line development market. The advantage of using human cell lines for protein production is factored in through the prospects of the resultant recombinant protein to bear post-translational modifications which are consistent with the endogenous human proteins.

Increasing burden of disease had propelled the development of new treatment pathways for diseases such as cancer and neurological disorders. The applications of hybridoma cell lines and recombinant cell lines in the development of therapeutic proteins has led to the growth in demand of cell line development market. The human cell lines, specifically the stem cell lines hold a potential stance for the treatment of various degenerative diseases, and hence paves way to novel drug therapy in regenerative medicine.

Moreover, the increasing development and production of biosimilars, owing to the patent expiry of branded therapeutics has positively impacted the growth of the cell line development market. The global scale development of bio therapeutics with cell line development has further fostered the development of a number of protein based therapeutics, assisting the growth of high-expression cell lines. These factors promote the expansion of the cell line development market on a global scale.

The global cell line development market expanded at 6.1% CAGR over the past 8 years from 2013 to 2021. The market is expected to expand at a considerable growth rate over the next six years (2022-2028) at a CAGR of close to 7.5%

cell line development market

Request Complete TOC Of this Report @ https://www.futuremarketinsights.com/toc/rep-gb-7566

According to a latest research by Future Market Insights (FMI), the global cell line development market size is anticipated to account for over US$ 7,200 Mn, in terms of value, by 2028 end. The report on cell line development market further projects significant growth potential with CAGR at 7.2% through 2028.

Rapid increase in prevalence of cancer and neurology disorders and lack of efficient treatment solution for these diseases has created the need of more advanced and efficient treatment pathway. Companies and government organizations are investing on research and development activities and are also focusing more on cell line development in search of new cellular pathway to develop novel drugs. The increased spending on biosimilar R&D from exiting biopharmaceutical companies would provide boost to cell line development market.

In recent time the contract research organizations are focusing on cell line development and cell line research activities. According to National Institutes of Health (NIH) the estimated total federal spending on all type of stem cell line research for 2017 is US$ 1.58 Bn. In developing countries like India, government is supporting cell line development through national funding agencies like Department of Biotechnology (DBT), Indian Council of Medical Research (ICMR), and Department of Science and Technology (DST).

Regenerative medicines are the next generation treatment solution and Cell Line Development or Cell Culture is a vital part for regenerative medicine. Increasing demand of regenerative medicines in cancer treatment would positively impacting the growth of Cell Line Development market over the forecast period.

The biopharmaceutical companies operating in development of novel drug line are expected to hold promising revenue opportunity in cell line development market.

Future Market Insights (FMI) has segmented the cell line development market based on product type, cell line source type, end user, type of cell line and region.

Product type segment in cell line development market is segmented into media and reagents, equipment and accessories. Reagents and Media are required from incubation to preservation of cell lines. These products are expensive and have repetitive use in cell culture or bio-production. Reagent and media segment in cell line development market is expected witness noteworthy growth in terms of revenue owing to rapid increase in demand in cell culture and cell based assays.

Cell line development market by cell line source is categorized into mammalian cells and non-mammalian cells. Mammalian cell line development is anticipate to witness significant growth in overall cell line development market. This growth of mammalian cells segment in cell line development market is driven by increased production of biologics drugs which require mammalian cells. Increasing antibody production is the major driving factor behind the growth of mammalian cell lines segment in cell line development market.

Mammalian cell lines are used to create therapeutic proteins through genetic building and antibodies through viral infection. For example, Gaucher’s disease, which is a genetic disorder characterized by lack of β-glucocerebrosidase enzyme and can be treated by Cerezyme which is a recombinant enzyme produces in mammalian cell lines. Mammalian cell lines are also useful in production of antibodies and other therapeutic agents such as specific binding proteins that can neutralize disease causing agents in the body. For example Under cell line type segment in cell line development market, recombinant cell line development are the most demanding type of cell line due to large application in biologics production, protein interaction, gene activation, toxicity testing and drug screening.

Growing application recombinant cell line development in drug toxicity testing is expected to boost the growth of overall cell line development during the forecast period

North America and Europe cell line development market will dominate in owing to increasing government funding in cell line development research and rising spending on biosimilar developments. Asia Pacific cell line development market is expected to grow at a high growth rate due to increased number of research organization engaged in novel biologics and biosimilar fastest revenue growth in overall cell line development market.

The Asia Pacific region in Cell line development market is anticipate to witness increasing demand of biopharmaceuticals and regenerative medicines are expected to boost the growth of the cell line development market.

FMI’s report tracks some of the key companies operating in the cell line development market, such as Selexis SA, GE Healthcare, Corning Incorporated, Thermo Fischer Scientific, Inc., American Type Culture Collection (ATCC), Lonza (Sartorius Stedim Biotech S.A.), Danaher Corporation, Merck KGaA, WuXi Biologics.

Key Market Segments Covered in Cell line development Market ResearchBy Product Type:

  • Reagent and Media
  • Equipment
  • Accessories and consumables

By Source Type:

  • Mammalian cell line
  • Non-mammalian cell line

By End User:

  • Biopharmaceutical Companies
  • Contract Research Organizations
  • Academics and Research Institutes
  • Biotechnology Companies

By Cell Lines:

  • Recombinant cell lines
  • Hybridomas
  • Continuous cell lines
  • Primary cell lines

By Region:

  • North America
  • Latin America
  • Europe
  • CIS & Russia
  • Japan
  • APEJ
  • MEA